Company / Income Tax
ADMA Biologics, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$35.7M
FY2025
5-year range
-$72.0M / $35.7M
FY2021-FY2025
Trend
+149.6%
vs FY2024
Sector context
#29 of 204
Health Care
What the data says
ADMA Biologics, Inc.'s income tax of $36M is higher than 86% of companies in the Health Care sector (FY2025). Increased from $0 to $36M over the past 2 years.
Based on SEC 10-K filings.
$36M in FY2025. Top quartile in the Health Care sector.
Increased from $0 to $36M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 204This company $35.7M Sector average $118.7M
▼
-69.9% below sector average
Key checks
Key Insights
- In FY2025, income tax increased 149.6% year-over-year.
- Ranks #29 out of 204 companies in the Health Care sector.
- Lowest income tax in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $35.7M | +149.6% |
| FY2024 | -$72.0M | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | +100.0% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026